The ABPI has responded to publication of the Government's new data strategy.
The pandemic has shown us the huge potential NHS data has to accelerate the development of new medicines and vaccines. Colette Goldrick, ABPI Executive Director, Strategy, Research and Partnerships
Colette Goldrick, the ABPI's Executive Director of Strategy, Research and Partnerships, said:
"The pandemic has shown us the huge potential NHS data has to accelerate the development of new medicines and vaccines.
"The Data Saves Lives Strategy is a landmark moment, and a major step forward in harnessing that potential. For the strategy to be a success it is critical that we operate with complete transparency and engage the public in a meaningful way.
"That is why over the past 5 months we have consulted with the public, patients, and NHS on new principles which will underpin how our industry members use NHS data to drive research and transform lives."
In February the ABPI launched a public consultation on draft governance principles for industry use of health data, and has since held several one to one sessions with key stakeholders representing patients, clinicians, the research community and the NHS to co-develop these principles.
The principles, due to be launched in the coming weeks, are designed to complement the already robust rules, regulations and guidelines already in place to ensure the safe and secure use of data for research purposes.